Screener
Cytokinetics CYTK Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Cytokinetics’s reported figures.
Based on trailing twelve months.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
FAQ
- What is Cytokinetics's asset turnover?
- Cytokinetics (CYTK) reported asset turnover of 0× in Q2 2026.
- How has Cytokinetics's asset turnover changed year-over-year?
- Cytokinetics's asset turnover decreased by 31.1% year-over-year, from 0.1× to 0×.
- What is the long-term trend for Cytokinetics's asset turnover?
- Over 5 years (2020 to 2025), Cytokinetics's asset turnover has grown at a -14.4% compound annual growth rate (CAGR), from 0.1× to 0.1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Cytokinetics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude